2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$181.69+$4.46 (+2.52%)
Price as of Oct 02, 2026 4:37 PM EDT- $10.0BMarket Cap
- 22.03%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$181.69+$4.46 (+2.52%)
Earnings Score
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 24.61% | ||
12-Month Momentum | 16.60% | ||
3-Month Risk Adjusted Momentum | 122.89% | ||
12-Month Risk Adjusted Momentum | 38.45% |
True Yield
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.06% |
Financial Health Score
Valuation | RGEN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |